A61M2207/00

FLUID BRIDGE CONFIGURED FOR USE VERTICALLY AND/OR UNDER COMPRESSION
20220387696 · 2022-12-08 ·

Disclosed embodiments may relate to a fluid bridge configured to facilitate negative -pressure therapy when used in a vertical orientation and/or under compression, and to systems and methods related thereto. In some embodiments, the fluid bridge may comprise an open-cell foam support manifold within an envelope. The support manifold may be configured to reduce negative-pressure drop across the length of the fluid bridge and/or to maintain therapeutic levels of negative pressure, for example despite vertical orientation and/or use under a compression garment.

Medical Fluid Line Connection Devices

A medical fluid line connector includes a body defining a central opening extending therethrough, a first projection extending from a first portion of the body, and a second projection extending from a second portion of the body, the second projection being circumferentially and axially offset from the first projection. The first portion of the body and second portion of the body are configured to separate from one another in response to a threshold amount of force being applied to the first projection and the second projection to rotate the first portion of the body and second portion of the body relative to one another.

Medical device with an additively applied converter

This disclosure relates to a medical device including a hard part and a converter. The hard part has fluid paths for conducting a medical fluid through the hard part. The converter is arranged to measure a characteristic of the medical fluid while the medical fluid is present in one of the fluid paths. At least a section of the converter is applied or superimposed to the hard part by at least one additive application method.

INHALER ARTICLE WITH A TWISTED DISTAL END ELEMENT

An inhaler article (110) comprises a body (112) extending along a longitudinal axis (A) from a mouthpiece end (113) to a distal end (114), a capsule cavity (116) defined within the body, and a distal end element (118) disposed at the distal end and extending to the capsule cavity. The distal end element comprises an element distal end (120), an element inner end (122), a solid core portion (124), and at least two grooves (126). The solid core portion extends from the element distal end to the element inner end. The at least two grooves are helical grooves that rotate about solid core portion along the longitudinal axis from the element distal end to the element inner end. The at least two helical grooves extend along an outer surface (128) of the distal end element.

PRIMARY CONTAINER ASSEMBLY WITH INTEGRATED FLUID PATH
20220379006 · 2022-12-01 ·

A primary container assembly includes a primary container defining a body having a proximal end defining an opening configured to receive a plunger, a distal end opposite the proximal end and defining an outlet, and a chamber extending from the proximal end to the distal end that is configured to receive a drug. The primary container assembly further comprises a tube extending from a first end that is integrally attached to the distal end of the primary container to a second end opposite the first end, where the tube defines a channel extending from the first end to the second end. The primary container assembly also includes a hollow needle configured to penetrate skin of a patient.

Nasopharyngeal Airway Devices
20220378598 · 2022-12-01 ·

A nasopharyngeal airway device includes an elongate body having a distal end and a proximal end. The elongate body has an outer surface defining one or more open channels extending along the elongate body. The nasopharyngeal airway device includes a securement component securely coupled to the elongate body. The securement component is configured to secure the nasopharyngeal airway device within a nostril of an individual.

METHOD FOR MANUFACTURING OXYGENATOR
20220378996 · 2022-12-01 ·

An oxygenator has a plurality of porous hollow fiber membranes comprising polypropylene for gas exchange, wherein each hollow fiber membrane has an inner surface that forms a lumen and an outer surface. The oxygenator is manufactured using a method which involves preparing a coating solution containing at least one compound selected from the group consisting of dopamine, salt of dopamine, and oligomer of dopamine; and bringing the inner surface or the outer surface of the hollow fiber membranes into contact with the coating solution for less than ten hours while blowing oxygen gas in the coating solution to form a dopamine polymer layer containing a polymer of the compound on the inner surface or the outer surface.

SYSTEMS AND METHODS FOR MONITORING DELIVERY OF MICRODOSES OF MEDICATION

Devices, systems, and methods are provided herein for delivering medication (e.g., insulin) via a wearable pump having a patch-style form factor for adhesion to a user's body. The reusable pump may be coupled to a disposable cap housing a microdosing system for delivering precise, repeatable doses of medication to a cannula configured to deliver medication to a target infusion area beneath the user's outer skin layer. The system further may include an applicator for inserting the cannula into the user's skin and/or applying an adhesive pad to the skin.

Portable transdermal administration patch apparatus and preparation method thereof

A portable transdermal administration patch apparatus comprises a communication control device and a pharmaceutical device which is fixed to and arranged at a lower end of the communication control device and electrically connected to the communication control device. The communication control device is formed of a micro-battery, a wireless control device and a micro-controller which are electrically connected. The preparation of the patch apparatus is achieved by: the preparation of medicinal patches and non-medicinal patches, the mounting of electrodes, interfacing with a micro-controller, and the communication control system, and starting administration. The transdermal apparatus is wearable and can be remotely controlled, and is convenient for administration, in particular, for the situations of daily administration for elderly patients with chronic illness and when there are a larger number of admitted inpatients, where a nurse can pre-set the administration time and dose, thus saving time and efforts of medical staff.

Prefilled drug delivery device with reduced air gap
11511046 · 2022-11-29 · ·

A method of assembling a drug delivery device, comprising the steps of: inserting a piston rod in a nut portion of a cartridge assembly and rotating the piston rod until the piston rod distal end engages the cartridge piston, mounting a drive member on the piston rod in a rota-tional position being closest to a pre-determined rotational position, and rotating the drive member to the pre-determined rotational position.